LONDON, Dec 11 (Reuters) - GlaxoSmithKline is to invest another 200 million pounds ($330 million) on advanced manufacturing in Britain, the company said on Wednesday, underlining the draw of a tax break designed to encourage research and development.
Dec 6 (Reuters) - GlaxoSmithKline and Theravance Inc said on Friday that their combination therapy met the main goal of improving lung function in asthma patients in a late-stage trial.
PFE ) collaborated with GlaxoSmithKline ( GSK ) . The company will evaluate ..... Palbociclib in combination with GlaxoSmithKline 's MEK inhibitor "Mekinist ..... approved by the FDA in May 2013, GlaxoSmithKline will be responsible for conducting
campaign has now officially passed, visiting UK Prime Minister David Cameron has become a vocal supporter of GlaxoSmithKline ( GSK ), the British drugmaker that was at the center of one of the biggest attacks against a multinational during
SHANGHAI (Reuters) - British Prime Minister David Cameron on Tuesday mounted a robust defense of GlaxoSmithKline 's business practices in China - where it is being investigated for alleged bribery - calling the firm "very decent".
SHANGHAI, Dec 3 (Reuters) - British Prime Minister David Cameron on Tuesday mounted a robust defence of GlaxoSmithKline 's business practices in China - where it is being investigated for alleged bribery - calling the firm "very decent".
BEIJING/LONDON (Reuters) - British Prime Minister David Cameron raised GlaxoSmithKline 's problems in China - where it is being investigated for alleged bribery - with political leaders on Monday as the drugmaker emphasized its commitment to doing business there.
continued commitment to China," a GlaxoSmithKline ( GSK +0.1% ) spokesperson says ..... week. Witty's presence comes as GSK faces allegations of corruption ..... China represents but a fraction of GSK 's global pharmaceutical revenues
Takeda Pharmaceutical ( OTCPK:TKPHF ) has named 20-year GlaxoSmithKline veteran Christophe Weber as the candidate to become its next ..... in its 232-year history. Weber, who is the president of GSK 's vaccines division in Belgium, will become Takeda's
company include Roche Holding AG ( OTCQX:RHHBY ), GlaxoSmithKline plc . ( GSK ), Arena Pharmaceuticals ( ARNA ), and Vivus Inc. ( VVUS ). Except GSK , other three companies have FDA-approved anti-obesity